Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
80.44B | 80.47B | 80.85B | 86.79B | 76.56B | 76.48B | Gross Profit |
25.90B | 25.91B | 25.24B | 30.86B | 26.55B | 25.52B | EBIT |
3.50B | 3.91B | 5.00B | 11.30B | 7.93B | 6.44B | EBITDA |
6.95B | 10.64B | 10.42B | 13.92B | 11.62B | 9.44B | Net Income Common Stockholders |
3.71B | 5.45B | 5.86B | 7.79B | 6.16B | 4.67B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
17.99B | 16.42B | 9.56B | 22.69B | 19.88B | 18.64B | Total Assets |
160.24B | 164.82B | 155.94B | 155.46B | 150.06B | 125.28B | Total Debt |
5.73B | 5.79B | 2.52B | 3.08B | 3.05B | 2.93B | Net Debt |
-12.26B | -10.62B | -7.04B | -10.81B | -6.33B | -4.51B | Total Liabilities |
33.63B | 35.40B | 35.36B | 36.88B | 35.61B | 29.31B | Stockholders Equity |
126.61B | 129.42B | 120.58B | 118.58B | 114.45B | 95.98B |
Cash Flow | Free Cash Flow | ||||
0.00 | 4.59B | -9.55B | 5.66B | 3.50B | 4.12B | Operating Cash Flow |
0.00 | 7.91B | -7.59B | 8.43B | 6.60B | 8.16B | Investing Cash Flow |
0.00 | -1.06B | 853.00M | -2.39B | -3.33B | -3.72B | Financing Cash Flow |
0.00 | -533.00M | -6.35B | -2.90B | -2.65B | -2.43B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥161.30B | 5.18 | 30.22% | 1.61% | 5.27% | ― | |
77 Outperform | €155.35B | 14.30 | 10.97% | 2.90% | 7.11% | -0.53% | |
75 Outperform | ¥104.77B | 14.40 | 2.75% | 8.95% | 4.60% | ||
74 Outperform | $81.94B | 16.63 | 15.32% | 3.43% | -2.62% | 26.11% | |
73 Outperform | ¥87.36B | 20.37 | 5.15% | 0.03% | -23.96% | ||
70 Neutral | $593.88B | 11.00 | 6.70% | 3.77% | 3.72% | 6.31% | |
61 Neutral | $11.29B | 10.17 | -6.88% | 2.97% | 7.41% | -8.93% |